# Bright Minds Biosciences Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Bright Minds Biosciences (DRUG)

- Source: PR Newswire M&A
- Published: 2026-11-02T23:26:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/bright-minds-biosciences-investigation-notice-levi--korsinsky-notifies-investors-of-pending-investigation-into-bright-minds-biosciences-drug-302926911.html
- Canonical: https://groundlevelnews.com/story/bright-minds-biosciences-investigation-notice-levi-korsinsky-notifies--c5efd4/

The FDA cited mouse toxicity findings and insufficient pharmacokinetic and juvenile-toxicity data when it placed Bright Minds' planned Phase 2 BMB-101 epilepsy trial on partial clinical hold. An investigation is underway on behalf of DRUG investors who suffered losses. NEW YORK, Nov. 2,...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._